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normative view of UT derives from its universal sweep
and consequent lack of an external criterion.
CONCLUSIONS: The normative interpretation of UT
leads to circular reasoning or an inﬁnite regress, forcing
the recognition that the normative aspect of UT lies in the
decision to apply UT, not in UT per se.
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mended to effectively incorporate Japan into global OR
plans/protocols: 1) a Japan OR expert should ﬁrst review
draft global OR plans/protocols and prospectively iden-
tify critical success factors in Japan, then 2) Japan OR
expert should draft Japan plans/protocols, and 3) estab-
lish a strong feedback loop from global OR to the Japan
OR expert to incorporate Japan input in global plans/
protocols. Critical success factors in Japan include: 1)
academic expert assistance; 2) feasibility assessment; 3)
institutional commitment; 4) strategic ﬁt with Japan.
Building draft Japan plans/protocols requires a prelimi-
nary assessment of Japan’s medical environment: 1) clin-
ical practice; 2) epidemiology; 3) political, sociological,
ethnic and health care ﬁnancing issues; 4) regulatory
issues. Establishing a strong communication link between
Japan and global OR will ensure that the Japan plans are
integrated into the global OR plans/protocols.
CONCLUSION: Global outcomes research plans/proto-
cols must incorporate Japan. Working with a Japan OR
expert is highly recommended so that global research
plans adequately reﬂect an awareness of critical success
factors and the local medical environment in Japan.
PMI37
INTEGRATION OF INTERNATIONAL INPUT
INTO INSTRUMENT DESIGN:TRANSLATABILITY
ASSESSMENT
Conway K, Mear I
Mapi Research Institute, Lyon, France
OBJECTIVES: The last 20 years have seen the develop-
ment of numerous PRO measures mostly however within
and for one culture. Based on the assumption that the
original concepts are universally appropriate, instruments
destined for international use are translated following 
a standardized procedure (linguistic validation). This
process however reveals the interdependence of transla-
tion and original and the importance of integrating an
international component into the design of instruments,
which can be done through a Translatability Assessment.
The presentation will illustrate the methodology and the
advantages of this new approach.
METHODS: A translatability assessment can be deﬁned
as an international critical review of a pre-ﬁnal original
in collaboration with the developer. In the absence of
international development, this may be a cost and time
effective compromise between the WHO approach to
instrument development and translation. The translation
process usually reveals difﬁculties when adapting the
format, instructions, concepts, idiomatic expressions,
response scales or demographic items to different lan-
guages. The translatability assessment proposes to review
these aspects and suggest re-formulations in the original
considering the context and constraints of other lan-
guages/cultures.
RESULTS: Several examples of the impact of the Trans-
latability Assessment on the original wording will be
given. For instance, although the term “work” in English
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Doherty J
Pharmacia Inc,Tokyo, Japan
Simultaneous global pharmaceutical development, regis-
tration and outcomes research (OR) strategies are now
commonplace. However, incorporating Japan into global
OR plans is a challenge.
OBJECTIVE: This paper addresses the concerns of global
OR researchers by presenting a systematic approach to
incorporating Japan into global research protocols and
strategies.
METHODS: Informal interviews with managers involved
in global R&D or OR planning and a literature review
of pharmacoeconomic studies was conducted. Based on
knowledge gained from several years of actual experience
conducting outcomes research in Japan, these informa-
tion sources were synthesized into a recommended ap-
proach for incorporating Japan into global OR plans.
RESULTS: 39 published studies were found in the 
Japanese and English literature from 1980–2001,
however, no mention of global research protocols was
found. Based on interviews three activities were recom-
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may refer both to a paid job and voluntary work, other
languages may require different expressions to convey
this global notion. The reference to “daily activities” may
be an alternative facilitating international harmonization
across languages and pooling of data. Similarly, reference
to “patient initials” being inappropriate for Chinese lan-
guages, replacing the original with “patient record
number” can improve international acceptability.
CONCLUSION: The Translatability Assessment may be
a practical and easy way to integrate an international
component in the design of new measures, thereby facil-
itating the subsequent translation by anticipating and
solving its difﬁculties.
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OBJECTIVE: There is limited information about the
structure of current pharmacoeconomic fellowship pro-
grams. The purpose of this study is to describe the struc-
ture of pharmacoeconomic fellowship programs from 
the fellow perspective.
METHOD: This was an observational cross-sectional
web-based study. A questionnaire was administered to
fellows currently enrolled in a pharmacoeconomic fel-
lowship program. A list of fellows was identiﬁed from 
the American College of Clinical Pharmacy (ACCP) and
the International Society for Pharmacoeconomics and
Outcomes Research (ISPOR) directories, and personal
contact information. An email, which included a descrip-
tion of the study along with an ISPOR web-site link for
accessing the survey, was sent to each identiﬁed fellow. 
In addition, all ISPOR members were sent an email
describing the study and an advertisement was posted on
the ISPOR web-page to increase survey participation.
RESULTS: A total of 34 fellows completed the web-based
survey. Of these, 79% had a PharmD degree before apply-
ing for a fellowship program and 79% indicated that the
fellowship program was located in at least two sites, pre-
dominantly an academic institution and pharmaceutical
industry. In terms of available resources, all sites had a
medical library, while 88% had computer centers, and
only 56% had data analysis centers from clinical studies.
Regarding staff qualiﬁcations, respondents stated that
97% of preceptors had an advanced degree, such as
PharmD or PhD, and 72% had 5 years or more of expe-
rience in pharmacoeconomics and outcomes research. 
In addition, 28% of preceptors had completed at least 
one fellowship training experience.
CONCLUSIONS: This study described the current struc-
ture of pharmacoeconomic fellowship programs from the
fellow perspective. Such results may be beneﬁcial for
organizations and institutions wishing to modify and
improve the structure of their fellowship programs.
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Comparison of utilisation of resources between hospitals
is a common procedure in benchmarking. Although to be
able to compare, homogeneous groups of patients should
be selected.
OBJECTIVES: This paper veriﬁes the comparison of util-
isation of resources for knee procedures.
METHODS: A sample of 13 hospitals was selected to
compare patients who were treated for knee procedures.
Only patients admitted in DRG 222 were recruited for
the study. Data on utilisation of resources concerning
medical procedures, medical imagery, use of drugs and
clinical biology was studied.
RESULTS: After data validation 2.076 patients were
included in the study. Between the hospitals a signiﬁcant
difference in the use of resources was notiﬁed. Neverthe-
less a general conclusion was too confounding because of
the case-mix in the hospitals. Further analysis found that
the main reason was the difference in operating tech-
nique. The differentiation between groups could not be
made on the basis of the ICD-9 code only. Based on the
national coding system of procedures additional group-
ing techniques were possible. Those hospitals in which the
arthroscopy is a common technique, the use of resources
is signiﬁcant lower in all the resource domains studied. In
the use of conventional radiology, the group of patients
with arthroscopy had lower correlations with the volume
of resources (r = .89 vs. r = .95). The analysis of operat-
ing procedures showed even more differences in the 
correlation between the use of resources and the group 
of patients (with arthroscopy (r = .409) versus without
arthroscopy (r = .904)).
CONCLUSION: When the use of resources is compared
between patients with knee procedures it is very impor-
tant to differentiate in the technique that is used. The use
of DRG and ICD-9 codes is not speciﬁc enough to make
the comparison possible.
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